Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharm Biopharm ; 158: 222-232, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33279603

ABSTRACT

To reduce cost and time for product development, an ideal strategy for the development of oral extended release (ER) product is to identify the desired formulation with minimum needsfor clinical evaluation. The aim of this work was to demonstrate the feasibility of adopting a "prediction-then-validation" strategy for the development of oral ER formulations. Instead of the traditional approach using multiple ER formulations for IVIVC development, an enteric-coated fast release formulation was successfully utilized for the development of a biopredictive tool to estimate the drug release from enteric coated polymeric ER formulations in the intestine. A TS1 (time scale factor between Tvitro and Tvivo equals to 1) system was designed and developed, based on which the in vivo pharmacokinetic (PK) performance of ER formulations in dog and in human were well predicted prior to in vivo evaluations. The model further passed a posteriori validation using the criteria for level A IVIVC and, as designed, provided a Tscale value of 1 for the IVIVC model.


Subject(s)
Delayed-Action Preparations/pharmacokinetics , Drug Carriers/chemistry , Models, Biological , Administration, Oral , Adult , Animals , Area Under Curve , Biological Availability , Cellulose/analogs & derivatives , Cellulose/chemistry , Cross-Over Studies , Delayed-Action Preparations/administration & dosage , Dogs , Drug Evaluation, Preclinical/methods , Drug Liberation , Feasibility Studies , Female , Healthy Volunteers , Humans , Intestinal Absorption , Intestinal Mucosa/metabolism , Intestine, Small/metabolism , Male , Middle Aged , Solubility , Tablets , Young Adult
2.
Int J Pharm ; 523(1): 133-141, 2017 May 15.
Article in English | MEDLINE | ID: mdl-28284921

ABSTRACT

Optimizing powder flow and compaction properties are critical for ensuring a robust tablet manufacturing process. The impact of flow and compaction properties of the active pharmaceutical ingredient (API) becomes progressively significant for higher drug load formulations, and for scaling up manufacturing processes. This study demonstrated that flow properties of a powder blend can be improved through API particle engineering, without critically impacting blend tabletability at elevated drug loadings. In studying a jet milled API (D50=24µm) and particle engineered wet milled API (D50=70µm and 90µm), flow functions of all API lots were similarly poor despite the vast difference in average particle size (ffc<4). This finding strays from the common notion that powder flow properties are directly correlated to particle size distribution. Upon adding excipients, however, clear trends in flow functions based on API particle size were observed. Wet milled API blends had a much improved flow function (ffc>10) compared with the jet milled API blends. Investigation of the compaction properties of both wet and jet milled powder blends also revealed that both jet and wet milled material produced robust tablets at the drug loadings used. The ability to practically demonstrate this uncommon observation that similarly poor flowing APIs can lead to a marked difference upon blending is important for pharmaceutical development. It is especially important in early phase development during API selection, and is advantageous particularly when material-sparing techniques are utilized.


Subject(s)
Powders/chemistry , Carboxymethylcellulose Sodium/chemistry , Cellulose/chemistry , Microscopy, Electron, Scanning , Particle Size , Rheology , Silicon Dioxide/chemistry , Stearic Acids/chemistry , Tablets/chemistry , Technology, Pharmaceutical
3.
Biomacromolecules ; 12(4): 977-86, 2011 Apr 11.
Article in English | MEDLINE | ID: mdl-21401021

ABSTRACT

The synthesis of new polymeric biomaterials using biocompatible building blocks is important for the advancement of the biomedical field. We report the synthesis of statistically random poly(carbonate-ester)s derived from lactic acid and dihydroxyacetone by ring-opening polymerization. The monomer mole feed ratio and initiator concentration were adjusted to create various copolymer ratios and molecular weights. A dimethoxy acetal protecting group was used to stabilize the dihydroxyacetone and was removed using elemental iodine and acetone at reflux to produce the final poly(lactide-co-dihydroxyacetone) copolymers. The characteristics of the copolymers in their protected and deprotected forms were characterized by (1)H NMR, (13)C NMR, GPC, TGA, and DSC. Hydrolytic degradation of the deprotected copolymers was tracked over an 8-week time frame. The results show that faster degradation occurred with increased carbonate content in the copolymer backbone. The degradation pattern of the copolymers was visualized using SEM and revealed a trend toward surface erosion as the primary mode of degradation.


Subject(s)
Biocompatible Materials , Carbonates/chemistry , Dihydroxyacetone/chemistry , Lactic Acid/chemistry , Polymers/chemistry , Calorimetry, Differential Scanning , Chromatography, Gel , Esters , Magnetic Resonance Spectroscopy , Microscopy, Electron, Scanning , Thermogravimetry
4.
Proc Natl Acad Sci U S A ; 107(24): 11014-9, 2010 Jun 15.
Article in English | MEDLINE | ID: mdl-20534478

ABSTRACT

We report the design of an injectable synthetic and biodegradable polymeric biomaterial comprised of polyethylene glycol and a polycarbonate of dihydroxyacetone (MPEG-pDHA). MPEG-pDHA is a thixotropic physically cross-linked hydrogel, displays rapid chain relaxation, is easily extruded through narrow-gauge needles, biodegrades into inert products, and is well tolerated by soft tissues. We demonstrate the clinical utility of MPEG-pDHA in the prevention of seroma, a common postoperative complication following ablative and reconstructive surgeries, in an animal model of radical breast mastectomy. This polymer holds significant promise for clinical applicability in a host of surgical procedures ranging from cosmetic surgery to cancer resection.


Subject(s)
Biocompatible Materials/chemical synthesis , Absorbable Implants , Animals , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacokinetics , Dihydroxyacetone , Drug Design , Female , Humans , Hydrogels , Injections , Mastectomy/adverse effects , Materials Testing , Microscopy, Electron, Scanning , Models, Animal , Polycarboxylate Cement , Polyethylene Glycols , Postoperative Complications/prevention & control , Rats , Seroma/prevention & control
5.
J Biomed Mater Res A ; 93(2): 776-82, 2010 May.
Article in English | MEDLINE | ID: mdl-19653301

ABSTRACT

We have developed a rapid acting, rapidly resorbable, non-toxic, topical hemostatic agent comprised of a PEGylated, polymerized sequence of dihydroxyacetone (MPEG-pDHA) that is highly effective in vivo. Twenty-eight Sprague-Dawley rats underwent left lateral hepatectomy. To the cut edge of the liver, rats received MPEG-pDHA (50 mg), normal saline (0.5 mL), or Instat (50 mg), a commercially available hemostatic compound. Bleeding time and total blood loss were quantified. Coagulation studies and scanning electron microscopy were performed on phlebotomized blood combined with MPEG-pDHA. Rats treated with MPEG-pDHA had significantly decreased bleeding time (97 s) and total blood loss (1.35 g) compared to normal saline (464 s and 3.83 g, p < 0.05 for each), and a significantly shorter bleeding time compared to Instat (165 s, p < 0.05). Histology confirmed that all MPEG-pDHA was metabolized within 3 weeks. The addition of MPEG-pDHA to whole blood did not significantly affect prothrombin time (12.0 s vs. 13.2 s, p = 0.130), partial thromboplastin time (27.0 s vs. 21.8 s, p = 0.118), or thrombin clotting time. MPEG-pDHA is an effective and rapidly resorbable hemostatic agent that may find broad hemostatic application in a wide range of surgical procedures.


Subject(s)
Biocompatible Materials , Dihydroxyacetone , Hemostatics , Animals , Biocompatible Materials/chemistry , Biocompatible Materials/metabolism , Blood Coagulation Tests , Dihydroxyacetone/chemistry , Dihydroxyacetone/metabolism , Hemostatics/chemistry , Hemostatics/metabolism , Hepatectomy , Liver/injuries , Male , Materials Testing , Molecular Structure , Polyethylene Glycols/chemistry , Polyethylene Glycols/metabolism , Random Allocation , Rats , Rats, Sprague-Dawley
6.
Tissue Eng Part B Rev ; 14(4): 377-91, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18816187

ABSTRACT

Postoperative tissue adhesion is a complex inflammatory disorder in which tissues that normally remain separated in the body grow into each other. Seroma is a common postoperative complication that arises when serous fluid collects in the space generated following surgeries that require extensive dissection and that create large empty spaces. Postsurgical tissue adhesion and seroma formation are two serious surgical complications that have received more attention recently from the biomaterials community. This paper provides a review of the pathogenesis and treatment of these surgical complications, with a thorough overview of biomaterial-based treatment and prevention methods.


Subject(s)
Biocompatible Materials , Seroma/prevention & control , Surgical Procedures, Operative , Tissue Adhesions/prevention & control , Animals , Carboxymethylcellulose Sodium/therapeutic use , Cellulose, Oxidized/therapeutic use , Dextrans/therapeutic use , Humans , Hyaluronic Acid/analogs & derivatives , Hyaluronic Acid/therapeutic use , Inflammation/prevention & control , Models, Animal , Phospholipids/therapeutic use , Polyethylene Glycols/therapeutic use , Postoperative Complications/prevention & control
7.
Biomacromolecules ; 7(11): 3239-44, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17096556

ABSTRACT

A biomaterial and its potential degradation products should be biocompatible, nontoxic, and removed by the body upon expiration of its functional lifetime. One historically successful approach is to create new materials from biomolecules that naturally occur in the human body. Herein, we report the synthesis and characterization of a polycarbonate based on dihydroxyacetone, a 3-carbon ketose, and an intermediate in the glucose metabolic pathway. The polymer was synthesized in a range of molecular weights ( approximately 8000 to approximately 37,500) by ring-opening polymerization. The C2 carbonyl of dihydroxyacetone is reactive to amines, and this reactivity was used to functionalize the polymer's surface in a one-step reaction by reductive amination. Additionally, contact angle measurements show the surface of poly(2-oxypropylene carbonate) is hydrophilic even though it is insoluble in water. Mechanical analysis of the polymer revealed it is exceptionally strong for an aliphatic polycarbonate. Specifically, poly(2-oxypropylene carbonate), M(w) 37 500, yielded a Young's modulus of 0.5 GPa and a compressive yield stress of 50 MPa. These values equal or exceed those of cancellous bone with similar dimensions.


Subject(s)
Biocompatible Materials , Dihydroxyacetone/chemistry , Glucose/metabolism , Magnetic Resonance Spectroscopy , Microscopy, Fluorescence , Molecular Structure
8.
Biomacromolecules ; 7(11): 3245-51, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17096557

ABSTRACT

Polymeric biomaterials have played an integral role in tissue engineering, biomedical devices, and targeted drug delivery. Block copolymers are especially important because their physical and chemical properties can be controlled by adjusting the ratio, size, and type of constituting blocks. Herein, the synthesis and characterization of diblock copolymers composed of poly(ethylene glycol) and a polycarbonate based on the metabolic intermediate, dihydroxyacetone, are reported. The length of the dihydroxyacetone-based block was controlled by adjusting the reactant feed ratios and initiator injection conditions. Intermediates and final products were characterized via (1)H NMR, GPC, DSC, TGA, and diffusion-ordered NMR spectroscopy. The dihydroxyacetone-based hompolymer is insoluble in water and most organic solvents, but is hydrophilic in nature. This, coupled with poly(ethylene glycol)'s solubility characteristics, allows the block copolymer to form nanoparticles in aqueous and organic anti-solvents. Dynamic light scattering and TEM results indicated the formation of spherical nanoparticles.


Subject(s)
Dihydroxyacetone/chemistry , Ethylene Glycol/chemistry , Nanoparticles , Polymers/chemistry , Calorimetry, Differential Scanning , Magnetic Resonance Spectroscopy , Microscopy, Electron, Transmission , Polymers/chemical synthesis
9.
J Control Release ; 116(2): 227-37, 2006 Nov 28.
Article in English | MEDLINE | ID: mdl-16963143

ABSTRACT

Polyethylenimine is a popular DNA transfection reagent, and many approaches have been explored to further enhance its transfection efficiency. Substitution of branched polyethylenimine's primary amine groups is an attractive approach because it is amenable to a variety of chemistries and is also implicated as a primary factor in its cytotoxicity. The purpose of this work was to serially substitute saturated hydrocarbons to branched polyethylenimine and determine what structure/function relationships exist between the hydrocarbon length and its degree of substitution, relative to transfection efficiency in multiple cell lines. Specifically, acetate, butanoate and hexanoate were conjugated to branched polyethylenimine (M(w) = 25,000) using an aqueous condensation protocol. Transfections were performed in culture using HeLa, NIH/3T3 and Clone 9 cell lines. Biophysical characteristics of the polyelectrolyte complexes were also measured (hydrodynamic diameter, relative binding affinity) and correlated to transfection efficiency. The results show that substitution of the primary amines generally increases transfection efficiency relative to unconjugated polyethylenimine, but increasing the degree of substitution beyond approximately 25 mol% generally decreases transfection efficiency from the optimum. Additionally, increasing hydrocarbon length generally decreased transfection efficiency. There was little correlation between particle size and binding efficiency to transfection efficiency.


Subject(s)
DNA/metabolism , Fatty Acids, Volatile/chemistry , Polyethyleneimine/chemistry , Transfection , Acylation , Animals , Binding Sites , Butyrates/chemistry , Caproates/chemistry , DNA/chemistry , Electrophoretic Mobility Shift Assay , Fatty Acids, Volatile/metabolism , HeLa Cells , Humans , Hydrophobic and Hydrophilic Interactions , Mice , Molecular Structure , NIH 3T3 Cells , Particle Size , Plasmids , Polyethyleneimine/metabolism , Sodium Acetate/chemistry , Structure-Activity Relationship , Transfection/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...